Rchr

J-GLOBAL ID：200901066065577320 Update date: May. 15, 2020

Koike Michiaki

コイケミチアキ | Koike Michiaki

Affiliation and department：

Research field (1)： Hematology and oncology

Research keywords (2)：臨床血液 , Clinical Hematology

Research theme for competitive and other funds (2)：

血液疾患における免疫学的機序の解明
癌におけるビタミンD₃誘導体の作用

MISC (7)：

M Koike, Sekigawa, I, M Okada, M Matsumoto, N Iida, H Hashimoto, K Oshimi. Relationship between CD4(+)/CD8(+) T cell ratio and T cell activation in multiple myeloma: reference to IL-16. LEUKEMIA RESEARCH. 2002. 26. 8. 705-711
M Koike, T Tasaka, S Spira, N Tsuruoka, HP Koeffler. Allelotyping of acute myelogenous leukemia: loss of heterozygosity at 7q31.1 (D7S486) and q33-34 (D7S498, D7S505). LEUKEMIA RESEARCH. 1999. 23. 3. 307-310
20-cyclopropyl-Cholecalciferol vitamin B₃ analogs : A unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Anticancer Research. 1999. 19. 1689-1698
Ovarian Cancer : Loss of heterozygosity frequently occurs in the ATM gene but the alterations do not occur in this gene. Oncology. 1999. 56. 160-163
M Koike, E Elstner, MJ Campbell, H Asou, M Uskokovic, N Tsuruoka, HP Koeffler. 19-nor-hexafluoride analogue of vitamin D-3: A novel class of potent inhibitors of proliferation of human breast cell lines. CANCER RESEARCH. 1997. 57. 20. 4545-4550

ｍore...

Professional career (1)：

(BLANK)

Committee career (1)：

日本臨床血液学会評議員

Awards (1)：

2004 - 順天堂大学医学部同窓か学術上冷笑

Association Membership(s) (5)：

日本臨床免疫学会 , 日本リンパ網内系学会 , 日本内科学会 , 日本血液学会 , 日本臨床血液学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM